Esther Cho insider trades: Keros Therapeutics (KROS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Esther reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | KROS | ↓ Sell | 4,485 | $10.29 | $46K | Direct | Aug 20, 2026 (2d) |
| Feb 18, 2026 | KROS | ↓ Sell | 4,745 | $16.35 | $78K | Direct | Feb 20, 2026 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KROS insiders
Open-market trades in the last 12 months
About Esther Cho's insider trades
Esther Cho is Chief Legal Officer at Keros Therapeutics (KROS). Since Feb 18, 2026, Esther has reported no open-market purchases and 2 sales worth $124K on SEC Form 4. In the last 12 months: 2 sales ($124K).
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KROS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.